278 related articles for article (PubMed ID: 1349270)
1. Drug-transporter proteins in clinical multidrug resistance.
Scheper RJ; Broxterman HJ; Scheffer GL; Meijer CJ; Pinedo HM
Clin Chim Acta; 1992 Mar; 206(1-2):25-32. PubMed ID: 1349270
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D; Skovsgaard T
Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic circumvention of multidrug resistance.
Ford JM; Hait WN
Cytotechnology; 1993; 12(1-3):171-212. PubMed ID: 7765325
[TBL] [Abstract][Full Text] [Related]
5. Studies on low-level MDR cells.
Belvedere G; Dolfini E
Cytotechnology; 1993; 12(1-3):257-64. PubMed ID: 7765328
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein.
Nielsen D; Maare C; Skovsgaard T
Biochem Pharmacol; 1994 Jun; 47(12):2125-35. PubMed ID: 7913318
[TBL] [Abstract][Full Text] [Related]
7. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
Safa AR; Agresti M; Bryk D; Tamai I
Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
[TBL] [Abstract][Full Text] [Related]
8. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
Chaudhary PM; Roninson IB
J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of P-glycoprotein expression in haematological malignancies.
Nooter K; Sonneveld P
Leuk Res; 1994 Apr; 18(4):233-43. PubMed ID: 7909572
[TBL] [Abstract][Full Text] [Related]
10. Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug.
Center MS
Cytotechnology; 1993; 12(1-3):109-25. PubMed ID: 7765322
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of multidrug resistant MDR1 transcript in acute myeloid leukaemia by non-isotopic quantitative cDNA-polymerase chain reaction.
Lyttelton MP; Hart S; Ganeshaguru K; Hoffbrand AV; Mehta AB
Br J Haematol; 1994 Mar; 86(3):540-6. PubMed ID: 7913825
[TBL] [Abstract][Full Text] [Related]
12. Genetic aspects of multidrug resistance.
Biedler JL
Cancer; 1992 Sep; 70(6 Suppl):1799-809. PubMed ID: 1355404
[TBL] [Abstract][Full Text] [Related]
13. Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein.
Roepe PD; Wei LY; Cruz J; Carlson D
Biochemistry; 1993 Oct; 32(41):11042-56. PubMed ID: 8105888
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.
Wulf G; Kluding H; Ho AD; Doerner M; Doehner H; Manegold C; Hunstein W
Leuk Res; 1994 Jul; 18(7):475-84. PubMed ID: 7912754
[TBL] [Abstract][Full Text] [Related]
15. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of functional P-glycoprotein in rat hepatoma cells.
Fardel O; Loyer P; Lecureur V; Glaise D; Guillouzo A
Eur J Biochem; 1994 Jan; 219(1-2):521-8. PubMed ID: 7905826
[TBL] [Abstract][Full Text] [Related]
17. Expression of the MDR1 gene in human cancers.
Goldstein LJ; Gottesman MM; Pastan I
Cancer Treat Res; 1991; 57():101-19. PubMed ID: 1686712
[No Abstract] [Full Text] [Related]
18. Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistance.
Boiocchi M; Toffoli G
Eur J Cancer; 1992; 28A(6-7):1099-105. PubMed ID: 1352696
[TBL] [Abstract][Full Text] [Related]
19. Two multidrug-resistant Friend leukemic cell lines selected with different drugs exhibit overproduction of different P-glycoproteins.
Savaraj N; Lampidis TJ; Zhao JY; Wu CJ; Teeter LD; Kuo MT
Cancer Invest; 1994; 12(2):138-44. PubMed ID: 7907527
[TBL] [Abstract][Full Text] [Related]
20. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
